Skip to content
InScanPublic rankings

CHE

Chemed Corp.

Health CareHealth Care ServicesNASDAQData 2026-09-25Live

$512.16

3.33%

563.77512.21460.65409.10357.5409-2509-25
Low 357.54 · High 563.772025-09-25 → 2026-09-25 · 252 bars

Indicators

Stored indicator values
IndicatorValueMeaning
Quality rank99.1Cross-sectional percentile built by the pipeline
RSI 1449.4Relative strength index over 14 days
SMA 20511.8220-day simple moving average
SMA 50523.2350-day simple moving average
EMA 20511.0220-day exponential moving average
ATR 1413.69Average true range over 14 days
RVOL 201.57Volume relative to its own 20-day average

Values are read from the stored feature table as of 2026-09-25, source yahoo. A dash means the pipeline has no value for that indicator; it is not replaced by an estimate.

Detected patterns

  • Volatility breakout

    2026-07-29

    BULLISH

    Strength 100%

  • Volatility breakout

    2026-07-01

    BULLISH

    Strength 100%

  • Volatility breakout

    2026-06-26

    BULLISH

    Strength 100%

  • Volatility breakout

    2026-04-24

    BULLISH

    Strength 100%

  • Volatility breakout

    2026-02-13

    BULLISH

    Strength 100%

  • Volatility breakout

    2026-01-15

    BULLISH

    Strength 100%

A pattern is a description of stored prices, not a prediction. Crosses need more than 200 bars, so an instrument with a short history shows fewer of them.

Related news

  • Chemed (CHE) Stock May Be 26% Undervalued On Franchise Territory Deal

    Chemed has logged a 20.9% gain year to date, which puts a spotlight on whether the current share price lines up with the cash the business is expected to generate. With investors weighing both its healthcare hospice operations and its Roto-Rooter services arm, the central issue is what that mix of businesses is really worth when you focus on its cash flows. The stock is up 20.9% year to date, so anyone looking at Chemed today is effectively asking if that move already reflects the cash the...

    Yahoo2026-09-26Sentiment —

  • UBS Initiates Coverage On Chemed with Buy Rating, Announces Price Target of $650

    UBS analyst A.J. Rice initiates coverage on Chemed (NYSE:CHE) with a Buy rating and announces Price Target of $650.

    Benzinga2026-09-25Sentiment —

  • Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns?

    Chemed Corporation (NYSE:CHE) announced on September 16 that its Roto-Rooter Services Company subsidiary had acquired the largest independent Roto-Rooter franchise for $60.6 million. The California territories serve approximately 11 million people, and the franchise generated annual revenue of $50 million to $55 million before the acquisition. For Chemed Corporation (NYSE:CHE), the purchase price represents approximately […]

    Yahoo2026-09-22Sentiment —